We are live on ! Find out more
TM

Tiger Management Portfolio holdings

AUM $22.8M
1-Year Est. Return 0.71%
This Fund
S&P 500
This Quarter Est. Return
-7.02%
1 Year Est. Return
+0.71%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$399M
AUM Growth
-$376M
Cap. Flow
-$338M
Cap. Flow %
-84.71%
Top 10 Hldgs %
57.38%
Holding
58
New
12
Increased
4
Reduced
13
Closed
20

Top Buys

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$23.6M
2
RCL icon
Royal Caribbean
RCL
+$23M
3
FDX icon
FedEx
FDX
+$17.3M
4
SPR
Spirit AeroSystems
SPR
+$15.5M
5
ASH icon
Ashland
ASH
+$3.93M

Sector Composition

Rank Sector Weight
1 Industrials 25.57%
2 Healthcare 21%
3 Communication Services 20.02%
4 Financials 11.54%
5 Consumer Discretionary 8.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GOOG icon
1
Alphabet (Google) Class C
GOOG
$4.22T
$27.1M 6.8%
727,780
-649,520
-47% -$23.3M
DAL icon
2
Delta Air Lines
DAL
$55.4B
$24.9M 6.25%
511,775
-500,200
-49% -$23.4M
NFLX icon
3
Netflix
NFLX
$290B
$24.6M 6.17%
2,408,000
-1,511,000
-39% -$14.8M
META icon
4
Meta Platforms (Facebook)
META
$1.64T
$24.2M 6.07%
212,000
-284,000
-57% -$30M
RCL icon
5
Royal Caribbean
RCL
$77B
$24.2M 6.06%
+294,300
New +$23M
CELG
6
DELISTED
Celgene Corp
CELG
$22.9M 5.74%
+228,840
New +$23.6M
STMP
7
PUT
DELISTED
Stamps.com, Inc.
STMP
$21.3M 5.33%
+200,000
New +$20.5M
BX icon
8
Blackstone
BX
$155B
$20.3M 5.09%
723,400
-554,600
-43% -$14.7M
FDX icon
9
FedEx
FDX
$74.7B
$20.3M 5.09%
+124,600
New +$17.3M
TEVA icon
10
Teva Pharmaceuticals
TEVA
$37.3B
$19.1M 4.78%
356,200
-239,100
-40% -$14M
UHAL icon
11
U-Haul Holding Co
UHAL
$13.9B
$18.2M 4.58%
510,620
-208,700
-29% -$7.26M
VISN
12
Vistance Networks Inc
VISN
$2.74B
$17.3M 4.33%
618,934
-635,166
-51% -$15.4M
SPR
13
DELISTED
Spirit AeroSystems
SPR
$15.4M 3.87%
+340,099
New +$15.5M
HZNP
14
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$14.4M 3.61%
868,477
+44,900
+5% +$786K
C icon
15
Citigroup
C
$217B
$12.7M 3.17%
303,000
-357,600
-54% -$14.9M
XPO icon
16
XPO
XPO
$25.2B
$12.6M 3.16%
1,187,475
-974,111
-45% -$8.49M
MGNX icon
17
MacroGenics
MGNX
$285M
$10.8M 2.7%
575,129
ENZY
18
DELISTED
Enzymotec Ltd
ENZY
$10.3M 2.59%
1,143,145
-19,700
-2% -$172K
RYAAY icon
19
Ryanair
RYAAY
$32.5B
$8.35M 2.09%
243,240
TTOO
20
DELISTED
T2 Biosystems, Inc
TTOO
$5.45M 1.37%
110
+25
+29% +$1.1M
ASH icon
21
Ashland
ASH
$3.14B
$4.39M 1.1%
+81,556
New +$3.93M
EQC
22
DELISTED
Equity Commonwealth
EQC
$4.05M 1.02%
143,600
+28,200
+24% +$762K
OPLN
23
Openlane
OPLN
$4.18B
$3.89M 0.98%
+269,484
New +$3.57M
PJT icon
24
PJT Partners
PJT
$4.3B
$3.76M 0.94%
156,365
+80,866
+107% +$2.08M
GILD icon
25
Gilead Sciences
GILD
$167B
$3.54M 0.89%
38,511
-355,900
-90% -$32.1M

Similar funds

Tiger Management's Q1 2016 Portfolio in Review

As of Q1 2016, Tiger Management held 58 positions worth $399M, down 49% from $775M the previous quarter. Its ten largest holdings account for 57% of the portfolio.

Tiger Management withdrew a net $338M in Q1 2016, closing 20 positions and reducing 13 holdings. Its most notable exit was Apple, an estimated $43.1M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 26% of assets, up from 19% a quarter earlier, followed by Healthcare and Communication Services.

Against the trend, Tiger Management opened a new position in Celgene Corp worth $22.9M.

  • Tiger Management's largest Q1 2016 buy was Celgene Corp: 228,840 shares worth $22.9M.
  • Tiger Management added most to PJT Partners in Q1 2016, an estimated $2.08M increase.
  • Tiger Management's biggest Q1 2016 reduction was Gilead Sciences, cutting an estimated $32.1M.
  • Tiger Management fully exited Apple in Q1 2016, selling an estimated $43.1M.
  • Tiger Management's ten largest holdings make up 57% of its $399M portfolio in Q1 2016.
  • Tiger Management opened 12 new positions and closed 20 in Q1 2016.
  • Tiger Management's portfolio value fell 49% quarter-over-quarter to $399M.

Based on Tiger Management's 13F filing for Q1 2016, filed 16 May 2016.